Диссертация (1174301), страница 28
Текст из файла (страница 28)
– P. 1193-200.134. Niessen, C.M. and Gottardi C.J. Molecular components of the adherens junction// Biochim Biophys Acta. – 2008. – 1778(3). – P. 562-71.135. Nogueira, R.B.et al. Immunoexpression of the COX-2, p53, and caspase-3proteins in colorectal adenoma and non-neoplastic mucosa // Einstein (SaoPaulo). – 2013. – 11(4). – P. 456-61.136. Nussrat, F.L.et al. Immunohistochemical Expression of ki-67 and p53 inColorectal Adenomas: A Clinicopathological Study // Oman Med J. – 2011. –26(4). – P.
229-34.243137. O'Brien, M.J. Hyperplastic and serrated polyps of the colorectum // GastroenterolClin North Am. – 2007. – 36(4). – P. 947-68, viii.138. Oh, K., Redston M., and Odze R.D. Support for hMLH1 and MGMT silencing asa mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated)carcinogenic pathway in the colon // Hum Pathol.
– 2005. – 36(1). – P. 101-11.139. Orlowska, J. Serrated polyps of the colorectum: histological classification andclinical significance // Pol J Pathol. – 2010. – 61(1). – P. 8-22.140. Oshima, C.T., Iriya K., and Forones N.M. Ki-67 as a prognostic marker incolorectal cancer but not in gastric cancer // Neoplasma. – 2005. – 52(5). – P.420-4.141. Owens, S.R., Chiosea S.I., and Kuan S.F. Selective expression of gastric mucinMUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids inmorphological diagnosis of serrated polyps // Mod Pathol. – 2008. – 21(6). – P.660-9.142.
Pai, R.K., Hart J., and Noffsinger A.E. Sessile serrated adenomas stronglypredispose to synchronous serrated polyps in non-syndromic patients //Histopathology. – 2010. – 56(5). – P. 581-8.143. Pap, Z.et al. Changes in immunoexpression of p53, Ki-67, Ets-1, APAF-1 andPTEN in serrated and conventional colon adenomas // Rom J Morphol Embryol.– 2015. – 56(4). – P.
1389-96.144. Papagiorgis P. C., Z.A.E., Tseleni S., Oikonomakis I. N., Sofras L., Patsouris E.,Nikiteas N. I. Disparate clinicopathological correlations of p53 and Bcl-2 incolorectal cancer // Molecular Medicine Reports. – 2012. – 5. – P.
377-82.145. Percicote, A.P., Leme, Fernanda El Ghoz, Almeida, Tammy Vernalha Rocha,Freitas, Ana Karyn Ehrenfried, Gugelmin, Elizabeth Schneider, Noronha, Lúciade. Immunohistochemical expression of p53, BCL-2, BAX and VEGFR1 proteinsin nephroblastomas // Jornal Brasileiro de Patologia e Medicina Laboratorial. –2013. – 49. – P. 50-56.146.
Pirani Carneiro, F., Ramalho, Leandra, Britto-Garcia, Sérgio, Ribeiro-Silva,Alfredo, Zucoloto, Sérgio, Immunohistochemical Expression of p16, p53, andp63 in Colorectal Adenomas and Adenocarcinomas. Vol. 49. 2006. 588-94.147. Pohl, H.et al. Incomplete polyp resection during colonoscopy-results of thecomplete adenoma resection (CARE) study // Gastroenterology. – 2013. – 144(1).– P. 74-80.e1.148. Puglisi, M.A.et al.
Colon cancer stem cells: controversies and perspectives //World J Gastroenterol. – 2013. – 19(20). – P. 2997-3006.149. Qasim, B., Ali, Husam, Hussein, Alaa. Immunohistochemical Expression of p53and bcl2 in Colorectal Adenomas and Carcinomas Using Automated CellularImaging System // Iranian Journal of Pathology. – 2012. – 7(4). – P.
215-223.150. Radtke, F. and Clevers H. Self-renewal and cancer of the gut: two sides of a coin// Science. – 2005. – 307(5717). – P. 1904-9.244151. Redston M., H.H., Odze R. D. Colorectal adenomas with mixed conventional andserrated adenomatous features: a clinicopathologic and immunophenotypic studyof 15 cases. // Laboratory Investigation. – 2007. – 87(1s).152. Rex, D.K.et al. Serrated lesions of the colorectum: review and recommendationsfrom an expert panel // Am J Gastroenterol. – 2012. – 107(9). – P.
1315-29; quiz1314, 1330.153. Rosty, C.et al. Serrated polyps of the large intestine: current understanding ofdiagnosis, pathogenesis, and clinical management // J Gastroenterol. – 2013. –48(3). – P. 287-302.154. Rubio C. A., K.A., Koha R., Ushoida M., Lindahl J., Kis L. L. β-Catenin Helicesin the Cytoplasm of Sessile Serrated AdenomaPolyps and ConventionalColorectal Adenomas // Anticancer Res. – 2015. – 35(2). – P. 929-934.155. Rubio, C.A.
and Jonasson J.G. Two Phenotypes of Traditional SerratedAdenomas Nationwide Survey in Iceland // Anticancer Res. – 2015. – 35(9). – P.4929-33.156. Rubio, C.A.et al. p53 up-regulation during colorectal carcinogenesis // AnticancerRes. – 2014. – 34(12). – P. 6973-9.157. Saha, M.N., Qiu L., and Chang H. Targeting p53 by small molecules inhematological malignancies // J Hematol Oncol. – 2013.
– 6. – P. 23.158. Salaria, S.N.et al. Sessile serrated adenomas: high-risk lesions? // Hum Pathol. –2012. – 43(11). – P. 1808-14.159. Sandmeier, D.et al. Serrated polyps of the large intestine: a molecular studycomparing sessile serrated adenomas and hyperplastic polyps // Histopathology. –2009. – 55(2). – P. 206-13.160. Sandmeier, D., Seelentag W., and Bouzourene H. Serrated polyps of thecolorectum: is sessile serrated adenoma distinguishable from hyperplastic polypin a daily practice? // Virchows Arch.
– 2007. – 450(6). – P. 613-8.161. Schlemper, R.J.et al. The Vienna classification of gastrointestinal epithelialneoplasia // Gut. – 2000. – 47(2). – P. 251-5.162. Shanmugam, C.et al. p53 Nuclear accumulation and Bcl-2 expression incontiguous adenomatous components of colorectal adenocarcinomas predictaggressive tumor behavior // J Histochem Cytochem. – 2008. – 56(3). – P. 30512.163. Shida, Y.et al.
Differentiation between sessile serrated adenoma/polyp and nonsessile serrated adenoma/polyp in large hyper plastic polyp: A Japanesecollaborative study // Mol Clin Oncol. – 2013. – 1(1). – P. 53-8.164. Sinicrope, F.A.et al. Increased apoptosis accompanies neoplastic development inthe human colorectum // Clin Cancer Res.
– 1996. – 2(12). – P. 1999-2006.165. Snover D. C. , A.D.J., Burt R. W., Odze R. D., Serrated polyps of the colon andrectum and serrated polyposis, in WHO classification of tumors. Pathology andgenetics. Tumors of the digestive system., / C.F. Bosman F. T., Hruban R. H.,Theise N. D., Editor. – 2010. –Springer-Verlag: Berlin. – P. 160-165.245166. Snover, D.C.
Update on the serrated pathway to colorectal carcinoma // HumPathol. – 2011. – 42(1). – P. 1-10.167. Snover, D.C., Batts, Kenneth P. Serrated Colorectal Neoplasia // SurgicalPathology Clinics. – 2010. – 3(2). – P. 207-240.168. Snover, D.C.et al. Serrated polyps of the large intestine: a morphologic andmolecular review of an evolving concept // Am J Clin Pathol. – 2005. – 124(3).
–P. 380-91.169. Sobecki, M.et al. The cell proliferation antigen Ki-67 organises heterochromatin// eLife. – 2016. – 5.170. Sobecki, M.et al. Cell-Cycle Regulation Accounts for Variability in Ki-67Expression Levels // Cancer Res. – 2017. – 77(10). – P.
2722-2734.171. Sousa, W.A.et al. Immunohistochemical evaluation of p53 and Ki-67 proteins incolorectal adenomas // Arq Gastroenterol. – 2012. – 49(1). – P. 35-40.172. Spring, K.J.et al. High prevalence of sessile serrated adenomas with BRAFmutations: a prospective study of patients undergoing colonoscopy //Gastroenterology. – 2006. – 131(5). – P. 1400-7.173. Stoian, M.et al. Apoptosis in colorectal cancer // J Med Life.
– 2014. – 7(2). – P.160-4.174. Su, T.et al. Comparison of biomarker expression between proximal and distalcolorectal adenomas: The Tennessee-Indiana adenoma recurrence study // MolCarcinog. – 2016. –.175. Takayama, T.et al. Colorectal cancer: genetics of development and metastasis // JGastroenterol. – 2006. – 41(3).
– P. 185-92.176. Tam, C.S., Seymour, John F., Roberts, Andrew W. Progress in BCL2 inhibitionfor patients with chronic lymphocytic leukemia // Seminars in Oncology. – 2016.– 43(2). – P. 274-279.177. Tateyama, H.et al. Apoptosis index and apoptosis-related antigen expression inserrated adenoma of the colorectum: the saw-toothed structure may be related toinhibition of apoptosis // Am J Surg Pathol.
– 2002. – 26(2). – P. 249-56.178. Tatsumi, N.et al. Expression of Cytokeratins 7 and 20 in Serrated Adenoma andRelated Diseases // Digestive Diseases and Sciences. – 2005. – 50(9). – P. 17411746.179. Terry, M.B.et al. Reliability in the classification of advanced colorectal adenomas// Cancer Epidemiol Biomarkers Prev. – 2002. – 11(7). – P. 660-3.180. Torlakovic, E.et al. Morphologic reappraisal of serrated colorectal polyps // Am JSurg Pathol. – 2003. – 27(1). – P. 65-81.181. Torlakovic, E.E.et al. Sessile serrated adenoma (SSA) vs.
traditional serratedadenoma (TSA) // Am J Surg Pathol. – 2008. – 32(1). – P. 21-9.182. Tsai, J.H.et al. Traditional serrated adenoma has two pathways of neoplasticprogression that are distinct from the sessile serrated pathway of colorectalcarcinogenesis // Mod Pathol. – 2014. – 27(10). – P. 1375-85.246183. Urbanski, S.J.et al.
Mixed hyperplastic adenomatous polyps--an underdiagnosedentity. Report of a case of adenocarcinoma arising within a mixed hyperplasticadenomatous polyp // Am J Surg Pathol. – 1984. – 8(7). – P. 551-6.184. Vakiani, E. and Yantiss R.K. Pathologic features and biologic importance ofcolorectal serrated polyps // Adv Anat Pathol. – 2009. – 16(2). – P. 79-91.185. van Putten, P.G.et al. Inter-observer variation in the histological diagnosis ofpolyps in colorectal cancer screening // Histopathology. – 2011. – 58(6).
– P. 97481.186. Vatn, M.H. and Stalsberg H. The prevalence of polyps of the large intestine inOslo: an autopsy study // Cancer. – 1982. – 49(4). – P. 819-25.187. Vogelstein, B.et al. Genetic alterations during colorectal-tumor development // NEngl J Med. – 1988. – 319(9). – P. 525-32.188. Vu, H.T.et al. Individuals with sessile serrated polyps express an aggressivecolorectal phenotype // Dis Colon Rectum.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
